BWL
ATOS icon

Bogart Wealth LLC’s Atossa Therapeutics ATOS Stock Holding History

Bogart Wealth LLC’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10 Hold
5
– – ﹤0.01% 1991
2026
Q1 		$26 Buy
+5
New +$32 ﹤0.01% 1790
2022
Q4 		– Sell
-33
Closed – – 1058
2022
Q3 		$0 Buy
+33
New +$479 ﹤0.01% 999

Other funds holding ATOS

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bogart Wealth LLC's ATOS Position: Q2 2026 in Review

Bogart Wealth LLC held its Atossa Therapeutics (ATOS) position steady in Q2 2026 at 5 shares worth $10. The position accounts for ﹤0.01% of the portfolio, ranked #1991.

Bogart Wealth LLC first reported a position in ATOS in Q3 2022 and has held it in 3 quarters since. The position peaked at $26 in Q1 2026. 31 funds tracked by Wall St. Rank hold ATOS as of Q2 2026.

  • Bogart Wealth LLC held 5 shares of Atossa Therapeutics worth $10 as of Q2 2026.
  • Bogart Wealth LLC left its Atossa Therapeutics share count unchanged in Q2 2026.
  • Atossa Therapeutics made up ﹤0.01% of Bogart Wealth LLC's portfolio in Q2 2026, its #1991 holding.
  • Bogart Wealth LLC first reported a position in Atossa Therapeutics in Q3 2022 and has held it in 3 quarters since.
  • Bogart Wealth LLC's Atossa Therapeutics position peaked at $26 in Q1 2026.
  • 31 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2026.

Based on Bogart Wealth LLC's 13F filing for Q2 2026, filed 24 Jul 2026.